Scanned by

    Norton

    Norton™ Safe Web

    The Effectiveness of Aprepitant in Treating Cough in Lung Cancer Patients

    The Effectiveness of Aprepitant in Treating Cough in Lung Cancer Patients

    01:21 |
    Download Here

    You Might Also Like:

    Dr Heymach on Updated AEGEAN Data in Resectable NSCLC

    Dr Heymach on Updated AEGEAN Data in Resectable NSCLC

    2:18 |
    Management of CLL Progression After Ibrutinib

    Management of CLL Progression After Ibrutinib

    4:07 |
    Trials of Ramucirumab in Gastric Cancer

    Trials of Ramucirumab in Gastric Cancer

    5:46 |
    Information Overload in Oncology: Episode 6

    Information Overload in Oncology: Episode 6

    4:19 |
    Case Study: Treating Papillary Thyroid Cancer

    Case Study: Treating Papillary Thyroid Cancer

    5:12 |
    Dr Krishnan on the Optimal Use of DKd in Relapsed/Refractory Multiple Myeloma

    Dr Krishnan on the Optimal Use of DKd in Relapsed/Refractory Multiple Myeloma

    1:42 |
    Chemotherapy Sensitivity in Soft Tissue Sarcoma

    Chemotherapy Sensitivity in Soft Tissue Sarcoma

    8:17 |
    Dr Klisovic on a Case Discussion of Momelotinib in Myelofibrosis With Anemia

    Dr Klisovic on a Case Discussion of Momelotinib in Myelofibrosis With Anemia

    3:13 |
    Dr Vaz Batista on Treating Patients With HER2+ Breast Cancer and Leptomeningeal Carcinomatosis

    Dr Vaz Batista on Treating Patients With HER2+ Breast Cancer and Leptomeningeal Carcinomatosis

    2:28 |
    Dr Aggarwal on Data for CAN-2409 Plus Valacyclovir and Continued ICIs in NSCLC

    Dr Aggarwal on Data for CAN-2409 Plus Valacyclovir and Continued ICIs in NSCLC

    2:55 |
    Peer Review Publications in Oncology: Episode 1

    Peer Review Publications in Oncology: Episode 1

    4:36 |
    OncLive News Network Preview: FDA Approval in Head and Neck Cancer

    OncLive News Network Preview: FDA Approval in Head and Neck Cancer

    0:33 |
    Obinutuzumab + Venetoclax for Frontline CLL

    Obinutuzumab + Venetoclax for Frontline CLL

    9:15 |
    Local Control in Metastatic Soft Tissue Sarcoma

    Local Control in Metastatic Soft Tissue Sarcoma

    3:28 |
    Dr. Bazhenova on the Value in Attending OncLive State of the Science Summits

    Dr. Bazhenova on the Value in Attending OncLive State of the Science Summits

    1:14 |
    Dr Massarelli on Using Selpercatinib and Pralsetinib in Treating Advanced Non-Small Cell Lung Cancer

    Dr Massarelli on Using Selpercatinib and Pralsetinib in Treating Advanced Non-Small Cell Lung Cancer

    1:32 |
    Monitoring Patients with Iron Overload

    Monitoring Patients with Iron Overload

    5:57 |
    Case Study: HER2-Positive Oligometastatic Breast Cancer

    Case Study: HER2-Positive Oligometastatic Breast Cancer

    3:52 |
    Dr. Drilon Discusses the Results of the Phase I/II LIBRETTO-001 Trial

    Dr. Drilon Discusses the Results of the Phase I/II LIBRETTO-001 Trial

    3:05 |
    Dr Sonneveld on the Background of the D-VRd Regimen in Newly Diagnosed Myeloma

    Dr Sonneveld on the Background of the D-VRd Regimen in Newly Diagnosed Myeloma

    2:05 |